A new series of potent oxindole inhibitors of CDK2

By Luk K.-C.   Simcox M.E.   Schutt A.   Rowan K.   Thompson T.   Chen Y.   Kammlott U.   DePinto W.   Dunten P.   Dermatakis A.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 913-917

Elsevier

Access to resources Recommend Favorite

Synthesis and Biological Evaluation of Thienopyrrolizines, a New Family of CDK/GSK-3 Inhibitors

By Rochais Christophe   Lescot Elodie   Lisowski Vincent   Lepailleur Alban   Santos Jana sopkova-de oliveira   Bureau Ronan   Dallemagne Patrick   Meijer Laurent   Rault Sylvain  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 19, Iss. 6, 2004-12 ,pp. : 585-593

Informa Healthcare

Access to resources Recommend Favorite

Interplay Between the p53 Tumor Suppressor Protein Family and Cdk5: Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases Using Selective Cdk Inhibitors

By  

Molecular Neurobiology, Vol. 34, Iss. 1-2, 2006-08 ,pp. : 27-50

Humana Press, Inc

Access to resources Recommend Favorite

Interplay between the p53 tumor suppressor protein family and Cdk5: Novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors

By Schmid Gerald   Strosznajder Joanna   Węsierska-Gdek Józefa  

Molecular Neurobiology, Vol. 34, Iss. 1, 2006-08 ,pp. : 27-49

Humana Press, Inc

Access to resources Recommend Favorite

Cyclin Dependent Kinase (CDK) Inhibitors

By Trumpp A.  

Trends in Cell Biology, Vol. 9, Iss. 3, 1999-03 ,pp. : 122-122

Elsevier

Access to resources Recommend Favorite